G. A. Dashyan

483 total citations
22 papers, 320 citations indexed

About

G. A. Dashyan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, G. A. Dashyan has authored 22 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in G. A. Dashyan's work include Advanced Breast Cancer Therapies (12 papers), Breast Cancer Treatment Studies (9 papers) and Cancer Treatment and Pharmacology (7 papers). G. A. Dashyan is often cited by papers focused on Advanced Breast Cancer Therapies (12 papers), Breast Cancer Treatment Studies (9 papers) and Cancer Treatment and Pharmacology (7 papers). G. A. Dashyan collaborates with scholars based in Russia and Germany. G. A. Dashyan's co-authors include Р. М. Палтуев, Semiglazov Vf, А. А. Божок, В Г Иванов, Ольга Александровна Мельникова, Lev M. Berstein, В. В. Семиглазов, E.K. Ziltsova, Petr Krivorotko and Э. Э. Топузов and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

G. A. Dashyan

18 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. A. Dashyan Russia 4 275 228 96 86 79 22 320
Ольга Александровна Мельникова Germany 3 260 0.9× 212 0.9× 89 0.9× 77 0.9× 79 1.0× 5 297
E.K. Ziltsova Russia 4 252 0.9× 204 0.9× 88 0.9× 73 0.8× 80 1.0× 8 292
Р. М. Палтуев Russia 5 333 1.2× 270 1.2× 131 1.4× 105 1.2× 95 1.2× 35 394
Andrea Stefek Germany 7 144 0.5× 144 0.6× 31 0.3× 53 0.6× 34 0.4× 14 193
A. Dunant France 4 178 0.6× 219 1.0× 23 0.2× 99 1.2× 30 0.4× 4 291
Angels Arcusa Lanza Spain 5 146 0.5× 132 0.6× 34 0.4× 69 0.8× 40 0.5× 11 195
Vassilena Tsvetkova Italy 7 123 0.4× 181 0.8× 22 0.2× 65 0.8× 41 0.5× 14 242
Lizhen Zhu China 8 127 0.5× 135 0.6× 17 0.2× 91 1.1× 113 1.4× 18 273
Uriel Bohn Spain 9 68 0.2× 144 0.6× 96 1.0× 85 1.0× 23 0.3× 16 253
Maria Angela Bella Italy 9 97 0.4× 169 0.7× 106 1.1× 115 1.3× 43 0.5× 15 312

Countries citing papers authored by G. A. Dashyan

Since Specialization
Citations

This map shows the geographic impact of G. A. Dashyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. A. Dashyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. A. Dashyan more than expected).

Fields of papers citing papers by G. A. Dashyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. A. Dashyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. A. Dashyan. The network helps show where G. A. Dashyan may publish in the future.

Co-authorship network of co-authors of G. A. Dashyan

This figure shows the co-authorship network connecting the top 25 collaborators of G. A. Dashyan. A scholar is included among the top collaborators of G. A. Dashyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. A. Dashyan. G. A. Dashyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Semiglazova, Т. Yu., G. A. Dashyan, Р. М. Палтуев, et al.. (2021). Current approaches to the treatment of HER2‑positive breast cancer with brain metastases. SHILAP Revista de lepidopterología. 17(1). 27–34. 1 indexed citations
2.
Krivorotko, Petr, et al.. (2020). Immediate breast reconstruction using titanised mesh. SHILAP Revista de lepidopterología. 16(2). 13–18. 1 indexed citations
3.
Krivorotko, Petr, et al.. (2019). Neoadjuvant chemotherapy regimens for triple negative breast cancer patients. The Breast. 44. S70–S70. 3 indexed citations
4.
Vf, Semiglazov, В. В. Семиглазов, G. A. Dashyan, et al.. (2018). NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER. Siberian Journal of Oncology. 17(3). 11–19. 2 indexed citations
5.
Vf, Semiglazov, А. М. Belyaev, В. В. Семиглазов, et al.. (2018). CLINICAL AND BIOLOGICAL MODEL FOR EVALUATION OF THE EFFECTIVENESS OF SYSTEMIC THERAPY FOR BREAST CANCER. Voprosy Onkologii. 64(3). 289–297. 1 indexed citations
6.
Krivorotko, Petr, et al.. (2018). EXPERIENCE OF RECONSTRUCTION OF THE BREAST WITH THE USE OF THORACODORSAL FLAP. Voprosy Onkologii. 64(2). 206–210.
7.
Семиглазов, В. В., et al.. (2018). Ways to improve efficiency of endocrinotherapy of breast cancer: new targeted cells, new therapeutic opportunities. Фарматека. 12_2018. 39–48. 1 indexed citations
8.
Vf, Semiglazov, et al.. (2018). Future prospects for breast cancer immunotherapy. Meditsinskiy sovet = Medical Council. 12–16. 1 indexed citations
9.
Semiglazov, Vladimir, В Г Иванов, О. А. Иванова, et al.. (2017). NEOADJUVANT SYSTEMIC THERAPY FOR BREAST CANCER (RETROSPECTIVE AND PROSPECTIVE ANALYSIS). Voprosy Onkologii. 63(2). 256–260. 1 indexed citations
10.
Krivorotko, Petr, et al.. (2017). COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER. Tumors of female reproductive system. 13(4). 19–23. 1 indexed citations
11.
12.
Dashyan, G. A., Semiglazov Vf, Petr Krivorotko, et al.. (2016). Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases. Tumors of female reproductive system. 12(1). 46–51.
13.
Vf, Semiglazov, Р. М. Палтуев, В. В. Семиглазов, et al.. (2015). General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists). SHILAP Revista de lepidopterología. 11(3). 43–60. 5 indexed citations
14.
Dashyan, G. A., et al.. (2015). New prospects in the use of Kadcyla® in breast cancer. SHILAP Revista de lepidopterología. 11(4). 46–52. 1 indexed citations
15.
Semiglazova, Т. Yu., G. A. Dashyan, В. В. Семиглазов, et al.. (2015). Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer. SHILAP Revista de lepidopterología. 17(1). 19–24.
16.
Vf, Semiglazov, В. В. Семиглазов, G. A. Dashyan, et al.. (2010). 9 Breast-conserving surgery after preoperative endocrine therapy versus chemotherapy in postmenopausal patients with estrogen-receptor-positive breast cancer. European Journal of Cancer Supplements. 8(3). 60–60. 3 indexed citations
17.
Vf, Semiglazov, G. A. Dashyan, В. В. Семиглазов, et al.. (2009). 0177 Primary endocrine therapy versus chemotherapy in postmenopausal patients with ER-positive breast cancer: 5-year results. The Breast. 18. S63–S63.
18.
Vf, Semiglazov, В. В. Семиглазов, G. A. Dashyan, et al.. (2007). Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor‐positive breast cancer. Cancer. 110(2). 244–254. 224 indexed citations
19.
20.
Vf, Semiglazov, В. В. Семиглазов, В Г Иванов, et al.. (2003). Anastrazol (A) vs tamoxifen (T) vs combine (A+T) as neoadjuvant endocrine therapy of postmenopausal breast cancer patients. The Breast. 12. S39–S39. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ольга Александровна Мельникова Breakdown of academic impact, for papers by E.K. Ziltsova Breakdown of academic impact, for papers by Р. М. Палтуев Breakdown of academic impact, for papers by Andrea Stefek Breakdown of academic impact, for papers by A. Dunant Breakdown of academic impact, for papers by Angels Arcusa Lanza Breakdown of academic impact, for papers by Vassilena Tsvetkova Breakdown of academic impact, for papers by Lizhen Zhu Breakdown of academic impact, for papers by Uriel Bohn Breakdown of academic impact, for papers by Maria Angela Bella
Rankless by CCL
2026